ARCHIVES

NCI-Approved Cancer Center, Cooperative Group Trials

This article is from The Cancer Letter archive.

Vol. 30 No. 4 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

NCI awards $7.3 Million for Studies In Cancer communications

October 15, 1993

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

Physicians Not Giving Enough Narcotics For Effective Pain Control, M.D. Anderson Specialist Tells Seminar

April 14, 1989

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

April 22, 2005

MammoSite Radiation System Delivers Dose To Target Tissue

February 28, 2003

PRI Purchased By DynCorp; NCI Is Assured No Changes Will Be Made At Frederick

April 13, 1990